DOSAGE INDEX / SINGLE
Epitalon (Epithalon)
Research, reported schedules and supply planning.
Review Epitalon and Epithalon identity, telomerase experiments, corrected cell research and mouse findings with clear limits on human anti-aging claims.
Source: PeptideDosages.com. Independently written summaries of reported protocols, not validated treatment recommendations. Reviewed for transcription on September 21, 2026.
Research Protocol & Dosage
Source-reported examples · not treatment recommendations
- Amount
- 5 mg per day
- Frequency
- Once daily
- Cycle / observation period
- 20 days, followed by 4–6 months without dosing in the source
- Route / research model
- Subcutaneous
Titration & progression
The selected example uses a fixed amount; no stepwise titration is specified for this planning window.
| Phase | Amount per administration | Frequency |
|---|---|---|
| Days 1–20 | 5 mg | Daily |
Supply & Planning
Compare vial strengths here. A different vial size changes the available material, not the biological dose.
Diluent & formulation
Diluent compatibility is formulation-specific. A verified manufacturer instruction is still needed before bacteriostatic water or another diluent can be listed as suitable for this research material.
Vial comparison
Source example: 20-day planning window: 100 mg total material. Use this total below, or enter a different documented total for comparison.
| Vial strength | Vials needed |
|---|---|
| 10 mg | 10 |
Calculated from the displayed schedule.
Material minimum only: round total material ÷ vial content up to a whole vial. Actual supply may be higher because of single-use packaging, discard dates, dead space or losses. No validated multi-use storage period is assumed.
Reported Research Results
Selected observations from the cited research. Each finding retains its study population, formulation and limitations.
- A later study examined normal epithelial and fibroblast cells alongside two breast-cancer cell lines. It reported telomere extension in normal cells associated with hTERT and telomerase changes, while telomere extension in the cancer-cell lines involved alternative lengthening of telomeres, or ALT. The experiments therefore did not support treating every telomere response as the same biological event. [1]
- A 2001 study in female CBA mice reported longer lifespan and lower spontaneous-tumor incidence with Epithalon, while several measures, including body weight, food consumption and behavioral activity, were not changed. [2]
- A 2002 study in female HER-2/neu transgenic mice reported longer mean and maximum lifetimes and reduced breast-tumor-related outcomes. This was a particular cancer-prone animal model, not a human prevention trial. [3]
Sourcing & Vendor Information
No compound-specific affiliate destination is listed here yet. Browse the Vendors Index for the available supplier records and disclosed relationships.
Sources & Further Reading
Medical publications and supporting literature from the corresponding protocol bibliographies, combined across vial strengths. Supplier and commercial catalog references are excluded. Duplicate destinations appear once. Inclusion does not mean that a paper validates the reported dose, or that an ingredient study tests the finished blend.
Bibliography checked September 22, 2026: 12 entries mapped from 1 source page. Medical and supporting references are retained below; supplier entries are excluded.
- Original 2025 report
- Original mouse report
- Original transgenic-mouse study
- Int J Mol Sci (MDPI)Further reading · Listed in reference bibliography.
- PMC/BiogerontologyFurther reading · Listed in reference bibliography.
- Neuroendocrinology Letters (PubMed)Further reading · Listed in reference bibliography.
- Bull Exp Biol Med (PubMed)Further reading · Listed in reference bibliography.
- Alzheimer’s Drug Discovery FoundationFurther reading · Listed in reference bibliography.
- Johns Hopkins Arthritis CenterGeneral guidance · Listed in reference bibliography.
- WikipediaFurther reading · Listed in reference bibliography.
- CDCGeneral guidance · Listed in reference bibliography.
- Immunize.org (IAC)General guidance · Listed in reference bibliography.
- NCBI BookshelfFurther reading · Listed in reference bibliography.
- Subcutaneous Drug Injection Review (PMC)Further reading · Listed in reference bibliography.
Reported schedule reference: PeptideDosages.com. Research findings are summarized independently from the listed sources.